D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MRKR holding history
Marker Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRKR overviewAll 13F holders of MRKRFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −82,117−100.0% | Sold out | Holders |
| Q2 2022 | 82,117 | $27.0K | <0.1% | −16,090−16.4% | Reduced | Holders |
| Q1 2022 | 98,207 | $43.0K | <0.1% | −385,178−79.7% | Reduced | Holders |
| Q4 2021 | 483,385 | $459.0K | <0.1% | +27,343+6.0% | Added | Holders |
| Q3 2021 | 456,042 | $771.0K | <0.1% | −175,151−27.7% | Reduced | Holders |
| Q2 2021 | 631,193 | $1.76M | <0.1% | +603,794+2,203.7% | Added | Holders |
| Q1 2021 | 27,399 | $61.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.